300636 logo

Jiangxi Synergy Pharmaceutical Co., Ltd. Stock Price

SZSE:300636 Community·CN¥3.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300636 Share Price Performance

CN¥0
-8.00 (-100.00%)
CN¥0
-8.00 (-100.00%)
Price CN¥0

300636 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
1 Reward

Jiangxi Synergy Pharmaceutical Co., Ltd. Key Details

CN¥825.2m

Revenue

CN¥602.2m

Cost of Revenue

CN¥223.0m

Gross Profit

CN¥128.5m

Other Expenses

CN¥94.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 29, 2026
0.23
27.03%
11.45%
24.5%
View Full Analysis

About 300636

Founded
2004
Employees
1418
CEO
Zhengwei Pang
WebsiteView website
www.jxsynergy.com

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepressants, as well as antigout and urinary system medications. It also exports its products to Europe, the United States, Japan, South Korea, and other regions. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People’s Republic of China.

Recent 300636 News & Updates

Recent updates

No updates